Persistent-relapsing SARS-CoV-2 infection following rituximab treatment for autoimmune rheumatic diseases: diagnosis and outcomes

ABSTRACT:

SUBMITTER: Chavatza K 

PROVIDER: S-EPMC12281322 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature